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Abstract
Statistics in the United States (US) have shown an increase in the prevalence of Cardiovascular
Disease (CVD) or risk for developing CVD. Approximately 78 million American adults, 20
years and older, have hypertension, 31.9 million have elevated serum cholesterol levels, and 68.2
million use tobacco products. Within California, San Francisco (SF) was ranked 8th among
counties with adult residents that have CVD. It is estimated that approximately 1.02% of these
individuals will have a stroke each year and 16.25% will die from stroke. Of those that survive, it
is estimated that at least half will develop neurologic deficits, and at least a third will develop
post-stroke depression (PSD). The high prevalence of post-stroke depression (PSD) greatly
influences stroke survivor mortality, hospital length of stay (LOS), and Quality of Life (QOL)
further fueling the projected rise of indirect annual costs associated to the loss of productivity of
stroke survivors and ongoing healthcare costs. Despite best practice recommendations and
guidelines from health agencies, current stroke care processes of stroke care facilities deviate
from these recommendations and lack the inclusion of a post-stroke neuropsychiatric sequelae
protocol or screening measure that leaves PSD undetected and untreated. This project aimed to
implement the inclusion of a depression screening measure and (pharmacologic and nonpharmacologic) intervention in the current stroke care processes of a 395-licensed bed, urban,
general acute care hospital (GACH) located in the downtown Tenderloin area of San Francisco,
California. Despite the low volume of stroke patients admitted during the 3-month period, the
project was moderately successful on multiple levels. The project produced the intended
outcomes of cost-effective staff training and education on the timely administration of PSD
screening measures and intended pharmacological interventions. It was able to moderately raise
nurses’ comfort levels in the administration of BH screening questions and answering questions
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related to its use. Nurses reported moderate increase in confidence on the overall clinical utility
of PSD screening as part of stroke care processes. The project’s success on improving stroke
outcomes as it relates to timely screening and intervention of PSD was considered low. However,
there appears to be a strong link between good communication, good training, and staff
compliance to small tests of change aimed towards improving patient care. Ultimately,
depression screening and early intervention on post-stroke patients has the potential to provide
cost savings or cost avoidance equal to $29159.95 over a 3-month period.

Keywords: Post-stroke depression, Patient Health Questionnaire, Patient Health Questionnaire-2,
Patient Health Questionnaire-9, National Institutes of Health Stroke Scale, cardiovascular
disease, neuropsychiatric sequelae, selective serotonin-reuptake inhibitors, cognitive behavior
therapy
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Depression Screening and Early Intervention on the Post-Stroke Patient
Section I: Background Knowledge
Recent statistics of cardiovascular health in the United States (US) show an increase in
the prevalence of cardiovascular disease (CVD) or risk for developing CVD. Approximately 78
million American adults, 20 years and older, have hypertension, 31.9 million have elevated
serum cholesterol levels (>240 mg/dl), and 68.2 million use tobacco products. For children
between the ages of 2 to 19 years old, 23.9 million are considered overweight and obese while
12.7 million are obese (Go et al., 2014), putting them at risk of developing CVD later in life.
Approximately 800,000 of these individuals will have a stroke episode each year (Go et al.,
2014) and 130,000 will die from stroke (Kochanek, Xu, Murphy, Miniño, & Kung, 2011). Of
those that survive a stroke episode, at least half will develop neurologic deficits (Phipps, 1991).
Neurologic symptoms are the primary cause of disability among stroke survivors. These longterm residual impairments are debilitating and negatively affect the quality of life (QOL) poststroke. However, the concurrent development of neuropsychiatric symptoms on post-stroke
patients can further complicate post-stroke outcomes. Between 33 to 50 percent of stroke
survivors will develop clinically significant depressive symptoms at any stages of recovery
(Hackett, Yapa, Parag, & Anderson, 2005; Robinson, Starr, Kubos, & Price, 1983).
Stroke is a life changing and debilitating event, but a combination of stroke and
depression can be particularly devastating. The high prevalence of PSD greatly influences stroke
survivor mortality, hospital length of stay (LOS), and QOL further fueling the projected rise of
indirect annual costs associated to the loss of productivity of stroke survivors and ongoing
healthcare costs, from $33.65 billion to $56.54 billion within the next 20 years (Ovbiagele et al.,
2013).
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Overview of Relevant Theories
Numerous epidemiological, clinical, neuroimaging and neuropathology studies have been
conducted in an attempt to explain the definite etiology of PSD. The psychological hypothesis
for PSD suggests that social and psychological stressors associated with stroke triggers the
depressive episode of stroke survivors (Fang & Cheng, 2007). The psychosocial framework
views depression as resulting from the interplay of several domains of variables, including
personal and environmental resources, environmental stressors, and the individual's appraisal and
coping responses to specific stressful events (Billings & Moo, 1982). Similar to primary
depression, it is postulated that severity and frequency (i.e. more than one stroke episode)
increase the prevalence of PSD. Phipps (1991) suggested that post-stroke neurologic deficits,
permanence of loss of function and independence, and the stress of undergoing rehabilitation
predisposes, precipitates, and perpetuates depressive symptoms post-stroke.
The biological hypothesis of PSD is the most predominant among all of the theories that
attempt to explain the etiology of the disease. Several researches have utilized the biological
framework of stroke as means of correlating the following possible mechanisms to the
development of PSD: (a) lesion location, (b) neurotransmitters mechanism, (c) inflammatory
cytokines mechanism, and (c) gene polymorphism mechanism (Fang & Cheng, 2007). The site
of infarct or location of the lesion suggests an organic biological basis for the difference of
emotional reactions and development of mood disturbance post-stroke, with left-sided cortical
and sub cortical lesions having a high prevalence for PSD (Rajashekaran, Pai, Thunga, &
Unnikrishnan, 2013). The ability of the brain to rewire or reorganize itself after injury is also
believed to precipitate behavioral changes and post-stroke neuropsychiatric sequelae. It is also
postulated that repair activities within the brain post-stroke can cause PSD through alterations in
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the microenvironments of the parenchyma that eventually leads to the abnormal release of
neurotransmitters. An increase in glutamate and decrease serotonin and norepinephrine were
linked to PSD (Sanchez-Mendoza et al., 2014). The release of multiple inflammatory cytokines
by the parenchyma such interleukin (IL) 1β, IL-18, and tumor necrosis factor α, were also
associated with PSD (Fang & Cheng, 2007). A repeat length of polymorphism of Serotonin
Transporter (SERT) variants of 5-HTTLPR, STin2 VNTR, and rs25531, were all linked to
depression-susceptibility in people experiencing emotional trauma including PSD (Kohen et al.,
2008).
Neurobiological Etiology
There is currently no definite mechanism that defines the etiology of PSD and it appears
to be multifactorial in cause. However, several studies have suggested the strong correlation
between the changes in the microenvironment of the brain and the risk for developing PSD. The
American Psychiatric Association (2013) classifies PSD as Depressive Disorder Due to a
General Medical Condition (i.e. stroke). What makes PSD unique from typical depression is the
necessity for the diagnosing clinician to establish that the mood disturbance is etiologically
related to the medical condition through a physiological mechanism. Two considerations for
detecting PSD take its premise from the biological origin of the condition. Diagnosing clinicians
must assess the presence of a temporal association between onset, exacerbation, or remission of
the general condition. Onset for PSD can occur 1 day to months post-stroke with depression
severity strongly correlated with severity of stroke. The second consideration is the presence of
clinical features that are atypical of primary mood disorders. Although age can be considered a
risk for PSD with older adults being at higher risk for stroke, other features such as absence of
family history cannot be factored in to rule out PSD. Majority of the literatures suggest that
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neurochemical changes independent or triggered by lesion location can trigger PSD – with left
frontal strokes having the greatest risk compared to right frontal strokes (American Psychiatric
Association, 2013).
Onset and Course
The physiological changes of stroke are well documented. Ischemic changes in cell
structure begin almost as rapidly as ischemic changes in biochemistry (Gupta, Pansari, & Shetty,
2002). Stroke involves the formation of blood clots that blocks an artery or a break in a blood
vessel and prevents oxygenated blood from reaching the brain. Brain damage starts immediately
when brain cells start to die due to blood deprivation. It is estimated that 2 million brain cells die
every minute of a stroke (Go et al., 2014). After a stroke episode, new brain cells start to form to
compensate for the injury and form specialized contacts with other cells. It is postulated that
these new connections may not always be functional or communicate properly with neighboring
cells and other brain structures. The cascade of changes within the brain structure and its’
biochemistry post-stroke are associated to both post-stroke recovery and risk for developing PSD
and other neuropsychiatric disorders. The actual onset of PSD remains unclear and varies from
patient to patient. It is estimated that between 33 to 50 percent of stroke survivors will develop
clinically significant depressive symptoms at any stages of recovery (Hackett, Yapa, Parag, &
Anderson, 2005; Robinson, Starr, Kubos, & Price, 1983). Most depressive symptoms manifest
during the acute phase post-stroke and become more pronounced during acute rehabilitation,
days to weeks after stroke, with some experiencing depressive symptoms years post-stroke.
However, some patients show very subtle behavioral changes or may even be asymptomatic
during hospitalization and rehabilitation, that results in the under-diagnosis of PSD. (Robinson,
et al.,1983).
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Stroke Severity Measure
Currently, the National Institutes of Health Stroke Scale (NIHSS) is the most widely used
clinical assessment tool to evaluate post-stroke neurologic status. The NIHSS is a 15-item
assessment tool that evaluates the consequence of acute infarct on the following: (a) levels of
consciousness, (b) language, (c) neglect, (d) visual-field loss, (e) extraocular movement, (f)
motor strength, (g) ataxia, (h) dysarthria, and (i) sensory loss (National Institutes of Health, n.d.).
The following scores of the NIHSS are interpreted as follows: (a) 0 for no stroke symptoms, (b)
1 to 4 for having minor stroke, (c) 5 to 15 for moderate stroke, (d) 16 to 20 for moderate to
severe stroke, and (e) 21 to 42 for severe stroke. The NIHSS is a simple and reliable tool that can
be administered by clinicians at the bedside regularly, and has been shown as good predictor of
both short and long-term stroke outcomes.
Treatment and Care
Currently, there is no treatment specific to PSD. Historically, the main focus of poststroke recovery and conventional stroke care were geared towards rehabilitation. Post-stroke
rehabilitation takes its premise from the principles of neuroplasticity, the ability of the brain to
“rewire” to retrain itself to perform everyday functions through repetition of tasks. However, the
changes in the brain after a stroke are much more complex than this. Imbalances in brain
chemistry can lead to the development of a concurrent psychiatric condition. Studies have shown
that there is a negative correlation between severity of depression and 5HT2 receptor binding in
the left temporal cortex in left-sided stroke and low levels of CSF 5H1AA, the principle
metabolite of 5HT in PSD (Ramasubbu, Flint, Brown, Awad, & Kennedy, 1999). Randomized
trials show that antidepressants, particularly selective serotonin uptake inhibitors (SSRI), are
effective in the treatment of PSD (Gupta et al., 2002). Citalopram and fluoxetine have proven
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efficacy in the treatment and management of depression among stroke survivors. However, since
the etiology of PSD is not limited to the biological model and is considered multifactorial, a
multidisciplinary approach and the inclusion of several treatment modalities (e.g. cognitive
behavioral therapy (CBT), dialectic behavior therapy (DBT), etc.) other than pharmacologic
interventions may increase the chances for depression remission.
Guidelines and Recommendations
As the number of stroke cases each year increases and new research studies regarding
post-stroke sequelae are published, guidelines to stroke care continually evolve. Several national
and international organizations recommend the inclusion of PSD screening with stroke care. In
2011, the Brain Attack Coalition amended its recommendations for the establishment of Primary
Stroke Centers (PSC), to include new elements that may improve the care and outcomes of poststroke patients (Alberts et al., 2011) such as detection and treatment of co-occurring mood
disorders. Additionally, The Joint Commission (TJC) supports the inclusion of depression
screening and assessment of cognitive decline and other social implications of stroke during its
acute phase (Go et al. 2013). Similar recommendations were made by health agencies outside of
the US. In the United Kingdom (UK), the National Clinical Institute for Stroke recommended
screening for PSD within the first month post-stroke and review of the patient’s mood and
behavior (Hart & Morris, 2007).
Local problem
In a study Lund and Pheatt (2001), San Francisco (SF) was ranked 8th among California
counties with adult residents that have CVD and at risk for having a stroke. There are several
General Acute Care Hospitals (GACH) in SF, at least 5 of which are TJC-certified PSCs, which
cater to the healthcare needs of SF residents and that of other neighboring counties (Vega, 2014).
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Despite best practice recommendations and guidelines from several national and international
health agencies, (with the exception of Comprehensive Stroke Centers) current stroke care
processes deviate from these recommendations and lack the inclusion of a post-stroke
neuropsychiatric sequelae protocol or screening measure that leaves PSD undetected and
untreated. Additionally, because of the decline in reimbursements for BH care, majority of the
hospitals can no longer afford to offer such services in an inpatient setting.
Stroke remains one of the most common causes of disability among patients with CVD.
Designated PSCs and other health facilities caring for stroke patients must explore the
prevalence of post-stroke neuropsychiatric sequelae in the population that they are caring for and
should consider adopting measures for screening for PSD and providing appropriate
interventions. Hart and Morris (2007) examined the compliance of healthcare professionals in
screening for PSD. Of the 145 hospitals with stroke services examined, 88% had local protocols
in place for post-stroke psychological assessments. Reported compliance among these hospitals
was low, with a rate of only 50%. The researchers found it interesting that despite positive
attitudes of staff toward screening, the average intention to screen was low. The following
barriers to screening were identified: (a) time pressure, (b) feeling uncomfortable using the
available tool(s), and (c) concern than screening may trigger the disease or other depressive
symptoms. Additionally, many providers still believe that most cases of PSD resolves without
any PSD-specific interventions as post-stroke neurologic deficits improve during the
rehabilitation phase.
Intended Improvement Project/Purpose of Change
A proposal of change to meet the needs of individuals at risk for developing PSD was
identified by the project manager to implement in hopes of providing early detection and

DEPRESSION SCREENING AND EARLY INTERVENTION

15

treatment, for patients admitted in the hospital in an effort to improve stroke outcomes and
reduce costs associated with stroke care, prolonged rehabilitation, and long-term disability.
Despite being one of the few hospitals in the city that offer inpatient services for psychiatric and
behavioral health (BH) disorders, inpatient BH services are only limited to patients actually
admitted in the Behavioral Health Unit (BHU) while floor consults are reserved only to medical
patients with acute psychiatric symptoms (e.g. danger to self, danger to others, etc.). In
collaboration with the project sponsor, organizational leaders, physicians, and staff nurses on
stroke care areas, the project manager developed a plan to address this gap by introducing a
standardized screening measure and early intervention for PSD in the hospital’s current stroke
care processes. The project was approved by hospital’s regional Institutional Review Board
(IRB) and classified as a quality improvement (QI) initiative and do not meet the criteria for
human subject’s research under state and federal regulations (see Appendix B).
Aim Statement
As members of the stroke care team, the role of nurses and physicians was providing
accurate and timely screening for PSD and provide treatment for positive screens. Together with
nurse volunteers who served as resource nurses, the project manager conducted a small test of
change, screening patients for PSD in each stroke care areas for a 30-day period. High yield
areas were identified while low-to-no yield areas were excluded from the project which spanned
3 months. The project manager monitored and reported bimonthly to the nurse managers and
project sponsor. The project goal is 90% timely screening for PSD on all admitted stroke patients
and to provide appropriate intervention(s) for post-stroke sequelae, therefore reducing poststroke neurologic deficits as evidenced by improved pre-discharge NIHSS scores and reducing
the following: (a) falls, (b) hospital LOS, (c) post-stroke depressive symptoms, and (d) hospital
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readmission. Additionally, the project aimed to improve nurses’ comfort levels in administering
BH screening measures on patients that are typically considered non-psychiatric or
psychiatrically well.
Objectives
Nurses working in stroke care areas are responsible for assessing the need for psychiatric
and behavioral health intervention(s) of patients, utilizing the recommended screening tools (see
Appendices H and I). These nurses have the responsibility of ensuring that PSD screening is
administered on all admitted stroke patients. Specific objectives identified as part of the strokecare nurse included: (a) identify if the patient meets the criteria for PSD screening through
review of the most current National Institute of Health Stroke Scale (NIHSS) scores on Facial
Palsy and Best Language, (b) timely administration of the depression screening tool(s), on the
3rd day or after 72 hours of hospitalization , (c) concise and timely documentation of the
patient’s Patient Health Questionnaire (PHQ) score in the organization’s electronic health record
system (EHR), Cerner, using the Situation-Background-Assessment-Recommendation (SBAR)
format, and (d) assure that PSD treatment and/or other BH interventions ordered by the physician
are carried out on a timely manner.
Physicians attending to the care of stroke patients had the responsibility of assessing the
need for psychiatric and/or BH interventions during hospitalization and on the day of discharge.
Specific objectives identified as part of the attending physician’s responsibilities included: (a)
timely review of the patient’s PHQ score(s) and nurses’ SBAR entry, (b) order appropriate
pharmacologic and/or non-pharmacologic intervention, (c) timely request for BH and/or
neuropsychiatric consult if necessary, and (d) timely documentation of explanation and
justification for not ordering PSD intervention.
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These objectives were discussed with all involved organizational leaders, physicians, and
staff, to increase compliance to the project and its realization. The success of the PSD screening
project relied on the enthusiastic participation of staff. The project leader frequently surveyed the
involved units and engaged staff at least once a week, both during the testing, training, and live
phases of the project. Since nursing provides the most direct post-stroke care services, it was
essential to also gain the support of the organization’s Education Department to ensure the
continuity of the project and that competencies for the use and interpretation of the PHQ tools
are documented.
Review of the Evidence
Several studies have investigated the effects of depression on the stroke patient and it has
been found that PSD significantly impacts patient rehabilitation, function, recovery, and quality
of life (Chen, Guo, Zhan, & Patel, 2006). Additionally, PSD is also associated with increased use
of healthcare resources (Herrman et al., 2011; Williams et al., 2007). A review of the literature
was conducted using Fusion and Google Scholar to further support these claims and to identify
additional studies on stroke and PSD published between 1980 to the present. Search terms
included stroke, PSD, post-stroke, stroke treatment, stroke rehabilitation, stroke care, and
depression screening. The search yielded more than 80 articles. Twenty-five articles were
selected based on content and relevance to the project, while 6 were appraised using an evidence
table (see Appendix S).
Validity of Screening Measures
Lincoln, Nicholl, and Flannaghan (2003) conducted a cross-sectional study on the
validity of questionnaires in screening for PSD, mood and other neuropsychiatric sequelae.
Twenty stroke patients were recruited from hospital wards while an additional 123 were
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recruited from a randomized control trial of cognitive behavioral therapy (CBT). All 143
participants completed the following questionnaires: (a) Beck Depression Inventory (BDI), (b)
Wakefield Depression Inventory (WDI), and (c) General Health Questionnaire-28 (GHQ-28).
The authors found that patients who met the DSM’s criteria for depression scored significantly
higher on questionnaires than those patients who were not depressed, with correlational
variances ranging between 23 to 34%. BDI had an 83% sensitivity and a 44% specificity in
detecting PSD in relation to the DSM criteria for depression, while WDI had an 86% sensitivity
and a 50% specificity, and the GHQ-28 had an 81% sensitivity and a 68% specificity. The
findings of the study emphasized the limitations of standardized assessment measures and the
variations of prevalence rates among these screening tools on the detection of PSD. The
researchers concluded that although PSD screening measures are sensitive to PSD, they have low
specificity.
A similar study that aimed to determine the validity of screening measures for detecting
PSD was contacted by Turner et al. (2011). The researchers aimed to determine internal
consistency among the following screening tools: (a) Patient Health Questionnaire-2 (PHQ-2)
and Patient Health Questionnaire-9 (PHQ-9), (b) Hospital Anxiety and Depression Scale
(HADS), (c) Beck Depression Inventory-II (BDI-II), (d) Distress Thermometer (DT), and (e)
Kessler-10. Seventy-two participants were recruited in the study, aged 25 to 91 years; all were
three or more weeks post-stroke. Participants either self-completed each of the screening tools
using paper or by a touchscreen computer during one appointment. The researchers concluded
that, apart from the DT, all screening measures performed considerably well in accurately
detecting PSD and support recommendations on the inclusion of depression screening tools in
stroke care.
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Stroke-specific Geriatric Depression Scale
Clinicians face the challenge of accurately assessing PSD in a population where the
disease is complicated by both aging and disability. The elderly population has the highest
incidence of CVD and risk for stroke. Screening measures for depression are often too lengthy,
confusing for the elderly, and do not assess for the severity of the disease. Cinamon, Finch,
Miller, Higgins, and Mayo (2010) conducted a study on the development of a stroke-specific
depression screening measures for geriatric patients. A 17-item stroke-specific Geriatric
Depression Scale (SS-GDS) was developed that measured the following PSD symptoms: (a)
motor, (b) cognitive disability, (c) emotionalism, and (d) depressive symptoms. Ninety-one
stroke patients, aged 71 and older, all one-year post-stroke, were interviewed using the SS-GDS
over 3 points and yielded 240 interviews. Of those that screened positive for PSD, the following
major symptoms for depression were expressed by the participants: (a) worrying about the past,
(b) being in good spirits, and (c) being hopeful about the future. The researchers also noted that
PSD symptoms different from typical depression wherein symptoms are more pronounced 3
months after stroke.
The researchers concluded that SS-GDs has a 79% reliability in detecting and quantifying the
severity of PSD, and can have important practical applications for the refinement of stroke care
processes for the elderly.
Smiley Diagrams
Lee, Tang, Yu, and Cheung (2007) conducted a cross-sectional study on the clinical
utility of emoticons in screening for PSD. The purpose of the study was to determine the efficacy
of a simple, non-language-based, culturally neutral, non-verbal, and easy to administer screening
measure detecting PSD, particularly on elderly patients who suffer multiple functional losses.
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The tool consisted of 3 enlarged diagrams: (a) a happy face, (b) a flat face, and (c) a sad/tearing
face. Initially, the emoticon tool consisted of 5 diagrams that included a very happy and a very
sad face. All 5 diagrams were matched with a 5-point Likert scale. However, older participants
during the pilot found it difficult to differentiate between the very happy with happy and very sad
with the sad diagrams. The researchers decided to eliminate the smileys with quantifiers.
Meeting 5 of the DSM criteria meant that the participant was depressed. Two hundred fifty-three
participants, aged 50 and older, all monolingual Chinese, and all 1-month post-stroke, were
recruited from two regional hospitals in Hong Kong.
The researchers reported varying rates of sensitivity for each emoticon in detecting PSD:
(a) 75.9% for sad, (b) 98% for flat, and (c) 48.3% for happy. Similarly, varying rates of
specificity were reported for each emoticon: (a) 77.4% for sad, (b) 18.2% for flat, and (c) 73%
for happy. Because there was a strong negative correlation between the flat and happy emoticon,
but there was no such correlation between the flat and sad emoticon, the researchers speculate
underreporting of the sad emoticon among mildly depressed participants. The researchers
concluded that the positive predictive value for PSD of the emoticon to slightly exceeds 50%.
The performance of the visual tool appears promising, not as an alternative to other languagebased tools but as an adjunct tool for screening PSD in patients with low literacy and limited
linguistic capabilities.
Single-item Screening Tool
Screening tools are often lengthy, redundant, and confusing for patients for which the
tools are being administered on. With the competing demands in direct patient care areas,
clinicians often don’t have the time to properly explain the purpose of the screening measure and
go through each items listed at the pace of the patient is comfortable with. Watkins et al. (2007)
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conducted a study on the accuracy of a single-item screening tool for detecting PSD. The
researchers administered the Yale, a screening tool for PSD that only requires a simple “yes” or
“no” answer to one question, on 540 admitted stroke patients. Screening was administered at two
points post-stroke: (a) 2 weeks and (b) 3 months. The study found that the Yale had 85%
sensitivity and 84% specificity in detecting PSD at 2 weeks post-stroke. After 3 months, the Yale
had 95% sensitivity and 89% specificity, with an overall efficiency of 92% in detecting PSD.
The researchers also noted that the tool is promising when compared to other multi-item
screening measures such as the Geriatric Depression Scale (GDS), Hospital Anxiety and
Depression Scale (GHDS), and the General Health Questionnaire (GHQ). The researchers
concluded that a single-item tool can satisfactorily detect PSD and recommended the use of the
Yale when considering the need for further psychiatric and behavioral health interventions.
However, the researchers also cautioned clinicians in using the Yale on stroke patients with
moderate to severe cognitive and language deficits, as the tool may produce false results.
Zung Self-Rating Depression Scale
Identification of PSD risk factors is essential to develop specific post-stroke
neuropsychiatric interventions and preventative strategies during stroke recovery and
rahbilitation. A cross-sectional study was conducted by Bose and Shah (2012) to determine
whether depression levels are related to the following: (a) location of stroke, (b) gender, (c)
cause of stroke, (d) number of arteries involved, and (e) presence of other medical comorbidities. Participants in the study were recruited from various hospitals in Mumbai and Navi
Mumbai. The researchers administered the Zung Self-Rating Depression Scale (ZSRDS) on 100
stroke patients, all at least two-weeks post-stroke. The ZSRDS is a 20-item depression screening
tool that has a 93% predictive value of detecting depression when compared other commonly
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used screening measures. The researchers found that severity of depression is higher in rightsided stroke patients. Additionally, the researchers reported that there is no significant
relationship for stroke severity on gender, cause of stroke, number of arteries involved, and
presence of other medical co-morbidities. The researchers also support the active screening for
PSD beyond the acute phase post-stroke and extend out in rehabilitation.
Conceptual/Theoretical Framework
The theoretical framework for this project is based on Betty Neuman’s Systems Theory.
Neuman’s theory postulates that wellness is the condition in which all system parts and subparts
are in harmony with the whole system of an individual. The following basic assumptions of
Neuman’s Systems Theory (Neuman & Fawcett, 2010) were utilized:


Each patient system is a unique composite of factors and characteristics within a range of
responses contained in a basic structure.



Many known, unknown, and universal stressors exist. Each differ in their potential for
upsetting a client's usual stability level.



Each patient has evolved a normal range of responses to the environment referred to as
the normal line of defense. It can be used as a standard by which to measure health
deviation.



The particular inter-relationships of patient variables can, at any point in time, affect the
degree to which a client is protected by the flexible line of defense against possible
reaction to stressors.



When the flexible line of defense is incapable of protecting the patient against an
environmental stressor, that stressor breaks through the line of defense.
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The client is a dynamic composite of the inter-relationships of the variables, whether in a
state of illness or wellness. Wellness is on a continuum of available energy to support the
system in a state of stability.



Each patient has implicit internal resistance factors known as LOR, which function to
stabilize and realign the patient to the usual state of wellness.



Primary prevention is applied in patient assessment and intervention, in identification and
reduction of possible or actual risk factors.



Secondary prevention relates to symptomatology following a reaction to stressors,
appropriate ranking of intervention priorities, and treatment to reduce their noxious
effects.



Tertiary prevention relates to adjustive processes taking place as reconstitution begins,
and maintenance factors move them back in a cycle toward primary prevention.



The patient is in dynamic, constant energy exchange with the environment.
Similar to the concepts of the life cycle of project management, Neuman developed a

sequential nursing process for problem solving. The 6 steps in Neuman's Systems Model nursing
process was also used as the framework project development and implementation: (a)
assessment, (b) diagnosis through data collection, (c) goal setting, (d) planning the intervention,
(e) implementation of the plan, and (d) evaluation (Neuman & Fawcett, 2010).

Section III: Methods
Ethical Issues
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The project manager considered the following ethical principles throughout the course of
this project: (a) beneficence and non-maleficence, (b) patient autonomy, and (c) social justice. A
project statement of determination was submitted to the USF DNP department and the project
site’s IRB for review. The project was determined as a QI project and did not meet the criteria
for human subjects’ research under state and federal regulations.
Byars and Jorge (2015) conducted a study to review the ethical issues and implications
for healthcare providers on the detection of PSD. The neuropsychiatric sequelae of stroke may
include symptoms (e.g. apathy, anxiety, irritability, and impulsivity, etc.) that overlap with a
major depressive episode, mood disorder, post-traumatic stress disorder (PTSD), or even minor
depression. Post-stroke neuropsychiatric disorders such as PSD do not occur exclusively as an
impaired adjustment reaction to loss of functioning and increased responsiveness of one’s
mortality. The researchers found that patients with PSD are at risk of committing suicide up to 5
years after a stroke episode and approximately 7% will die of suicide. Healthcare providers
involved in the care of stroke patients need to identify and differentiate symptoms of PSD from
other neuropsychiatric disorders. The research provided several aspects of ethical dilemma that
healthcare providers encounter when caring for post-stroke individuals: (a) beneficence and nonmaleficence, (b) patient autonomy, and (c) equity.
Healthcare providers who introduce and administer health screening measures and
interventions to patients who have not requested them (nor have prior knowledge of their
availability) have the added responsibility of making sure that the benefits outweigh any possible
harm. PSD screening is not part of conventional stroke care. Acutely ill patients are already at an
emotionally vulnerable state due to numerous variables related to their hospitalization (e.g.
possible loss of independence, change in environment, etc.). Additionally, the societal stigma
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associated with mental illness further complicates patient engagement. Family members may
became defensive or dismissive during the initiation of the screening process and opt for the
patient to not be screened for PSD during hospitalization. The increase awareness on the risk of
developing or having post-stroke neuropsychiatric disorder, such as PSD, may prove distressful
to both patients and family members. Additionally, there is also the possibility that patients may
minimize symptoms to avoid being stigmatized or complicating their post-stroke care.
Healthcare providers unfamiliar or have limited experience in the use of behavioral health
screening measures may fear inducing unwarranted emotional distress to patients and family
members, or furthering post-stroke apathy and irritability. However, screening typically has no
impact on the patient’s risk of developing the disorder that is being screened for (Association of
Faculties of Medicine of Canada, n.d.).
The role of the project manager and staff nurses is to introduce PSD screening that
emphasize on expected improvement in stroke outcomes and not coerce participation. Explaining
the purpose of administering the screening measure in a therapeutic manner assures that
informed consent is properly obtained. Rather than overtly campaigning for population results
and evidence, emphasizing individual benefits of early screening and intervention for PSD
allows for the patient to have realistic expectations on the risk, intervention, and outcomes.
Healthcare providers must balance the duty of doing no harm and respecting the patient’s choice.
To avoid unintentionally dissuading patients, screening nurses are instructed to disclose the
following prior to screening: (a) PSD screening is currently only a recommendation and not a
mandate for PSCs, and (b) the PSD measure is a pilot project.
Non-native English speakers are less likely to be able to participate in the screening
process in the absence of an English-speaking family member or certified language interpreter.
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The project site cares for a large percentage of monolingual Chinese and Russians. Because of
this disadvantage, non-English speakers are at risk of not being afforded accurate and timely
screening and intervention for PSD. Hospitals and other healthcare organizations must make sure
that they have resources in place such as certified language interpreters (onsite or via phone) to
help in translating the screening questions. Using non-certified staff may lead to mistranslation
while using friends and family members may result in the patient under-reporting depressive
symptoms.
Setting
The setting for this project is a 395-licensed bed, urban, GACH located in the downtown
Tenderloin area of San Francisco, California. The hospital is certified by The Joint Commission
(TJC) as a Primary Stroke Center (PSC), and is committed to providing the most up-to-date and
evidenced-based stroke care. An average of 10 stroke patients per month are admitted through
the Emergency Department (ED), while the hospital’s Acute Rehabilitation Unit (ARU) also
receives an average of 10 post-stroke patients from other facilities.
Along with conventional stroke care, patients are routinely screened for stroke-related
neurologic deficits using the NIHSS (see Appendices I to K). The NIHSS is a 15-item, clinical
assessment tool used by trained clinicians to quantify the severity, determine intervention, and
predict outcomes of stroke patients. Impairments concerning several aspects of brain functioning
such as consciousness, vision, sensation, movement, speech, and language are given a score. A
baseline NIHSS score of 21 or more is classified as a severe stroke (National Institute of
Neurologic Disorders & Stroke, n.d.). With the exception of the BHU, all nurses in the project
setting are “stroke-certified”, with training and validated competencies in rendering evidencebased care to stroke patients, including the use of the NIHSS. Stroke severity is assessed on
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admission and discharge, in the ED, Medical-Surgical Unit (MSU), and ARU. NIHSS is
completed on admission, discharge, and every shift (8 hours) for all stroke patients in the
Intensive Care Unit (ICU). NIHSS scores are documented in the hospital’s electronic healthcare
record (EHR) system, using the Situation-Background-Assessment-Recommendation (SBAR)
format.
The progression of inpatient stay is dependent on the severity of stroke. From the ED, a
patient may be admitted to the ICU and transferred to the MSU when more stable, or may also be
admitted directly from the ED to the MSU. The stroke patient progresses from the MSU to ARU,
with an average length-of-stay (LOS) of 10 to 14 days. Post-stroke patients requiring long-term
care and rehabilitation are transferred to a Skilled Nursing Facility (SNF) while those with little
to no apparent neurologic deficits are discharged home. The ARU also receives an average of 10
post-stroke patients from other facilities with an average LOS of 7 to 14 days.
Planning the Intervention
The inclusion of a depression screening measure in the project site’s current stroke care
processes required extensive literature review from various online databases necessary to
increase the project manager’s knowledge on stroke and post-stroke neuropsychiatric sequelae. A
strength-weakness-opportunities-threats (SWOT) analysis was conducted to gauge whether
project objectives were attainable by identifying favorable and unfavorable internal and external
variables (see Appendix M). Based on the reviewed literature, SWOT analysis, and the project’s
theoretical framework, the project manager had 2 underlying assumptions: (a) at least one-third
of admitted stroke patients will screen positive for PSD, and (b) any meaningful change is often
met with resistance.
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The project manager also developed a Gantt chart (see Appendix E) to create a timeline
for project milestones and develop realistic and achievable deadlines for deliverables. This Gantt
chart was used to help monitor whether the project was moving as projected. Due to several
unforeseen events (e.g. loss of project sponsor, etc.), the timeline was revised and adjusted
accordingly to ensure that the project moved forward. Additionally, the sequence project of
deliverables was determined by developing a Work Breakdown Structure table (see Appendix
D).
Narrative of Responsibilities and Work Breakdown Structure
A formal diagram for the decomposition of the project’s deliverables was developed (see
Appendix C). Breaking down the project into small manageable components was necessary to
identify each component’s hierarchy and ensure prioritization of resources. The precursors and
mutually exclusive and co-dependent elements of each components were identified by
developing a project resource requirements table (see Appendix D). The work breakdown
structure is summarized as follows:


Review PSD literature: guidelines, etiology, and screening measures



Identify of validated depression screening measure



Map the current stroke care workflow



Perform a gap analysis



Map the proposed PSD screening workflow



Pre and post-live survey and review results



Create tool kit



Train resource nurses



Identify high volume units
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Pilot in stroke care areas: ED, ICU, MSU, and ARU



Train stroke care nurses (end-users)



Print screening tool and assemble resource binder



Go-live on stroke care units



Data Mining and project Evaluation



Present findings to organizational leadership



Integrate findings into DNP paper



Submit DNP with revisions and present project to committee
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Description of Project Resource Requirements
The project manager identified a designated PSC to serve as the site for project
implementation. The project manager contacted the hospital’s Nursing Education Director and
submitted the following documents required from student interns: (a) criminal background
check, (b) health clearance and immunization records, (c) student’s resume, and (d) preceptor’s
(DNP chairperson) resume. Additionally, a project prospectus was submitted for review and
cleared by the hospitals’ IRB.
This project required a project sponsor to serve as a liaison between the project manager
and organizational stakeholders. The project sponsor also served as an advisor/consultant by
helping the project manager navigate around encountered and potential barriers, identifying
stakeholders, and reviewing hospital policies and processes related to stroke care. The project
volunteered thirty minutes to an hour of his/her time with biweekly meetings or email
correspondence with the project manager. Throughout its course, the project had a total of three
different project sponsors.
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A significant portion of the project’s resource requirements included a dedicated number
of hours spent in all key phases of the project: (a) research, (b) testing, (c) staff training, (d) golive, and (e) evaluation. The project manager participated in the new hire orientation on the use
of the hospital’s EHR system and was given student access for conducting chart reviews and
audits. The project manager spent a combined 535 hours in all stages of the project.
This project required one physician champion that supports the inclusion of a PSD
screening measure on stroke care. The project manager and the ARU nurse manager met with the
lead stroke care physician who agreed to support the project. Additionally, the physician
champion directed the project manager to research articles relevant to PSD screening.
This project required at least one resource nurse to administer the PHQ tools for a month
on each identified stroke care areas: (a) ED, (b) ICU, (c) MSU, and (d) ARU. Resource nurses
were trained by the project manager on the use of the screening measures. Screening was
conducted during the resource nurses’ regular shift concurrent with routine patient care. No
additional compensation was provided and resource nurses were considered volunteers.
However, these nurses received “project hours” as part of their staff nurse III/IV portfolio.
In addition to the resource nurses, unit clerks were also tasked in making sure that new
stroke patients are logged into the project’s resource manual, and collected and filed all
completed screening forms in the patient’s paper chart.
All of the involved staff have been HIPPA trained and are compliant prior to the start of
related project activities.
Communication Responsibilities
The success of this project involved regular and effective communication between the
project manager and organizational stakeholders. The project manager had responsibilities in
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communicating with members the essential elements of successful PSD screening and
intervention. The project manager met with nurse managers and the project sponsor bi-weekly
and corresponded with them via email as needed to give status updates on each phases of the
project. Similarly, the project manager met with resource nurses bi-weekly.
Since the screening tool is not available in the organization’s EHR system, a strong emphasis
was placed on the timely screening for PSD of all admitted stroke patients by putting up
informational flyers on the nurses’ stations and staff break rooms on all stroke care areas. The
project manager’s contact information was made available for staff if questions regarding the
project arise.
Baseline data on staff’s comfort levels and perceptions on the use of BH screening tools
were collected via a self-administered survey form handed-out during nurses’ huddles and were
also available in each of the stroke care areas project resource binder. Nurses were also asked to
complete a similar, but slightly modified, post-live survey form. Nurses were provided training
and education on the administration of the PHQ tools via a “read and sign” project resource
binder. The project manager and the resource nurses conducted the staff in-service and signedoff nurses who completed the in-service from the unit roster. Feedback from staff were collected
and reviewed by the project manager. Survey results and feedback were also communicated to
the nurse managers and project sponsor for review and further feedback.
Nurses refer to the unit’s census to identify stroke patients and refer to the EHR system
for admission dates and most current NIHSS scores. Charge nurses and resource nurses also
remind staff of patients which are due depression screening. The results of the screen are
communicated to the attending provider verbally and by charting in the EHR.
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Upon completion of the data analysis, the project manager will present the outcomes of
this QI improvement project to his Doctor of Nursing Practice (DNP) chairperson and committee
members.
Implementation
The implementation of the project was supported by the elements and timeline
established in project’s work breakdown structure, resource requirements and Gantt chart (see
Appendices C to E). Based on these documents, 8 distinct phases were identified for the
successful completion of the project. These phases included: (a) review of evidence, (b)
workflow mapping and gap analysis, (c) identification and training of resource nurses, (d) pilot
testing, (e) training of staff nurses, (f) assembly of project live materials, (g) project go-live, and
(h) post-live and evaluation.
The project manager conducted a comprehensive literature review which was used in
identifying articles related to PSD. The author synthesized current PSD screening and
intervention guidelines, studies on the etiology of typical depression and PSD, PSD screening
studies and validated tools, intervention and treatment modalities. A study of the current stroke
care workflow was also conducted in consultation with the project sponsor, the stroke
coordinator, and nurse managers of stroke care units. From this, a gap analysis was completed
and it was identified that there is no standardized process to screen for and document PSD. A
new workflow was proposed that highlighted the inclusion of the PHQ-2 and PHQ-9 depression
screening tools (see Appendix G). PSD screening is due after 3 days or 72 hours post-hospital
admission. With input from the stroke coordinator, items 4 (Facial Palsy) and 9 (Best Language)
of the NIHSS were used to determine the exclusion criteria for PSD screening. Stroke patients
with complete facial paralysis and/or severe to global aphasia were excluded until an
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improvement in the said NIHSS items are observed. Additionally, patients with pre-existing
depression and other mood disorders who were already on an antidepressant regimen were also
excluded. Nurses administered the PHQ-2 (see Appendix H). If the patient scored 3 or higher on
the PHQ-2, nurses proceed in administering the PHQ-9 (see appendix I). If the patient scored 10
or higher on the PHQ-9, then this was indicative of a “positive” screen for depression. Nurses
documented their findings in the patient’s EHR using the SBAR format. The attending provider
reviewed the clinical note and decided on an appropriate intervention (e.g. BH consult, to start on
an antidepressant, outpatient BH follow-up, psychotherapy, etc.). Providers documented their
clinical impression in patient’s EHR. The completed depression screening tools were filed in the
patient’s paper chart and are electronically scanned by medical records after the patient had been
discharged.
The project manager capitalized on the hospital’s clinical nurse ladder program and
consulted with nurse managers in identifying potential resource nurses (staff nurse III/IVs) for
the project. These nurses served as volunteers and were trained by the project manager in the
administration of the PHQ-2 and PHQ-9. Pilot testing on high-volume stroke care units was
conducted for 4 weeks. Together with the resource nurses, the project manager was able identify
additional barriers and made appropriate changes to the proposed workflow. Both the ICU and
ED were removed the project because of low-yield results (see Appendix P). The project
officially went live in June 2015. Data mining for the first 3-months after implementation was
conducted. Staff was again asked to complete a survey. Project evaluation began on month 2 and
extended to 8 more weeks after the project go-live.
Results and findings were incorporated in the project manager’s paper and submitted to
his DNP committee for review. Revisions will be made on this paper based on the committee’s
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feedback and will be re-submitted after 2 weeks. A formal presentation of the project will follow
contingent upon approval of the DNP committee.
Barriers to Implementation
The project had several set-backs since inception. After a review of the hospital’s EHR
system, the project manager identified the lack of a validated depression screening tool for
clinicians. One of the initial objectives of this project was to have the PHQ-2 and PHQ-9 to be
built into the EHR system prior to going live with the project. The project manager intended to
have an automated clinical alert for positive screens. Unfortunately, the project site is part of a
larger hospital network and any “build requests” will be system-wide and will have to go through
the corporate office. Approval for build requests take at least 6 months to a year, with an
additional 3 months for building and testing. After consultation with the project sponsor and the
hospital’s clinical informatics educator, the project manager decided to abandon the electronic
format and instead opted to have the screening tools on a paper. The proposed workflow was
revised to reflect this change. Additionally, a Strength-Weakness-Opportunity-Threat (SWOT)
analysis (see Appendix M) was developed based on the following identified barriers for project
implementation:


Changes in Organizational Leadership
Two weeks after starting the program, the hospital’s Stroke Coordinator left the
organization. The project manager was able to meet and consult with her only once prior
to her departure. The Stroke Coordinator position remains vacant to date. Half way
through the project’s testing phase, the Director of Critical Care, who served as the
project sponsor and clinical liaison, and the Chief Nursing Officer (CNO) were
unexpectedly terminated by the hospital’s executive leadership. The project was on hold

DEPRESSION SCREENING AND EARLY INTERVENTION

35

for approximately 2 months until a new sponsor was identified. The former project
sponsor suggested that the project manager contact the hospital’s Director of Nursing
Education to discuss the future of the project. Fortunately, The Director of Nursing
Education agreed to be the new project sponsor. Two months after, the new project
sponsor also left the organization. Again, the project was on hold for approximately 2-3
weeks until a new sponsor was identified. This dilemma was communicated to the DNP
committee as the project’s progress was again in jeopardy. One of the committee
members suggested that the project manager contact the hospital’s Director of Clinical
Informatics in hopes of gaining new sponsorship. The Director of Clinical Informatics
agreed to be the new (3rd) project sponsor. Two months later, the Director of
Rehabilitation Services also left the organization.


Low Patient Volume
Being a small-sized hospital in an area with several bigger PSCs, the hospital only
receives an average of 10 stroke cases per month. Convincing internal stakeholders,
particularly providers, to accept a change in current stroke care workflow will be
difficult. Additionally, the medical units rely on BH providers for BH consults. Often
times, BH consults are not completed in a timely manner since the hospital only has two
psychiatrists, who also serve as attending providers for the inpatient BHU.



Low Yield
After discussion with the hospital’s stroke coordinator, it was determined that preexisting depressive and other mood disorders, complete facial paralysis, and severe
aphasia will serve as the exclusion criteria for post-stroke depression screening, lowering
potential number of depression screening candidates.
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Change Fatigue and Staff Compliance
On July 2014, the hospital had its PSC re-certification survey from TJC. It was
found that nurses were non-compliant in routine completion of the NIHSS on stroke
patients. As part of the hospital’s corrective plan of action, all nurses were re-educated on
the use of NIHSS. According to one of the nurse resources, “It will be difficult to expect
nurses to do something new when compliance is already low in something that they
should be doing in the first place”.
Methods of Evaluation

Time and Cost Summary
The project manager had a time-limited role in implementing the project. A Gannt chart
(see Appendix E) was developed to map out a timeline for project milestones. This helped the
project manager to navigate around time constraints and monitor whether deadlines for
deliverables were being met as projected. Due to several unforeseen events (e.g. loss of project
sponsor, etc.), several components of the chart was revised and adjusted accordingly to reflect
changes in deadlines. Approximately 36 weeks was spent conducting review of literature related
to stroke and PSD. The project manager spent 4 weeks in identifying an implementation site and
project sponsorship, and obtaining clearance from the site’s IRB. An additional 8 weeks was
spent meeting with key stakeholders. Training and testing took a combined 12 weeks to
complete. The project went live on June 2015 and was supported by the project manager and
resource nurses for 8 weeks. Staff surveys were conducted pre and post-live for 2 weeks each.
Review of data and project evaluation took 12 weeks. The project was completed at the end of
October 2015.
Cost-Benefit Analysis / Financial Outcomes
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The project manager developed a formal budget with estimated breakdown of expenses
(see Appendix F). Estimates were compared with actual costs to determine variances. The budget
for direct costs was $1,080.00 while actual direct costs were $978.50. Variance for direct costs
was 9.39%. The budget for indirect costs was $500.00 while actual indirect costs were $536.75.
Variance for indirect costs was -7.35%. An estimate of the opportunity costs for those involved
in the project was also included in the budget, merely as a reference. Opportunity cost for 535
project hours was $46,909.60 .
Financial outcomes were to be demonstrated by total project (direct and indirect)
expenses versus improved outcomes such fall episodes, LOS, and hospital readmission rate.
However, the process of measuring financial outcomes was more difficult than originally
expected due to accounting structures and billing processes. The sudden departure of the
hospital’s Stroke Coordinator and Director of Rehabilitation Services, individuals who had
access to the necessary data, further complicated analysis of patient outcomes and translating
them into financial outcomes. A summary table was developed to present estimated cost savings
and cost avoidance related to decrease in LOS and episodes of fall, for stroke patients who
screened positive for PSD and started on an SSRI (see Appendix T). According to Medi-Cal’s
Diagnostic Related Group (DRG) pricing calculator, base payment for stroke care is $17,415.00
for an average LOS 7.65 (California Department of Healthcare Services, 2015). The estimated
savings over a 3-month period for decrease in LOS was $6,140.11 for the MSU and $6,032.64
for the ARU. According to a study conducted by Exel et al. (2003), a single fall episode of a
stroke patient during hospitalization increases LOS by 71%. Based on this information, it is
estimated that savings over a 3-month period for 0 episodes of fall was $8.079.80 for the MSU
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and $10,422.65 for the ARU. The total estimated cost savings produced by the project over a 3
month period was $30,376.20.
Evaluation Criteria
This project was intended to involve all stroke care areas in the hospital in screening for
PSD on all admitted stroke patients. The evidence surrounding depression screening and positive
outcomes of early PSD intervention is strong but relied heavily on the involvement of a larger
population group to prove its short-term and long-term efficacy. In order for the project manager
to successfully implement this project, certain elements had to be removed (i.e. electronic
version of the tool in the EHR) and reduction in scope had to be initiated (i.e. exclusion of ICU
and ED after testing). Full evaluation of the project through staff surveys and patients’ chart
review was based on the following: (a) proficiency of resource nurses in educating other nurses
on the use of the PHQ depression screening tools, (b) accurate and timely administration of PHQ
tool(s) on stroke patient meeting the criteria for PSD screening, (c) nurses’ perception on the
clinical utility of BH screening measures and their comfort levels in administering such tools, (d)
clinical utility of BH screening measures for post-stroke patients as it relates to LOS, hospital
readmission, falls, and pre-discharge NIHSS scores. Because this program is in its beginning
stages, it will require ongoing evaluation and refinement in processes.
Analysis
Evidence of the successful implementation of the project towards the goal of early
screening and intervention for PSD on stroke patients was measured in 3 different stages: (a) prelive, (b) live, and (c) post-live. Results of pre and post-live staff surveys (see Appendices N and
O) and the screening and intervention results (see Appendix P) were reviewed and analyzed.
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A total of 76 nurses completed the pre-live survey. A high number of nurses expressed
moderate to high comfort levels in administering BH screening tools on patients, with a rate of
39.47% and 28.94% respectively. A few nurses reported no to low comfort levels, with a rate of
6.57% and 10.52% respectively, while 14.47% reported feeling neither comfortable nor
uncomfortable in administering BH screening tools to stroke patients. A high number of nurses
also reported moderate to high comfort levels in answering questions from patients and family
members as to why BH screening tools are being administered, with a rate of 36.84% and
32.89% respectively. A few nurses reported no to low comfort levels, with a rate of 5.26% and
9.21% respectively, while 15.78% reported feeling neither comfortable nor uncomfortable in
answering questions from patients and family members as to why BH screening tools are being
administered. Nurses who responded to the pre-live survey reported moderate to high confidence
in the value of BH screening tools on patients as it relates to stroke patient outcomes, with a rate
of 43.42% and 56.57% respectively. A high number of nurses reported that they either somewhat
agree or agree on recommending the use of BH screening tools on stroke patients, with a rate of
51.31% and 48.68% respectively, while 6.57% reported being unsure whether to recommend or
not. Additionally, 30.3% of nurses admitted that they have reported to a provider that a stroke
patient may require a BH consult or intervention at one point. Majority of the nurses reported
observing behavioral changes from stroke patients 2 to 3 days, post-hospital admission.
At month 1 of project go-live, a total of 10 stroke patients (4 in the MSU and 6 in the
ARU) who did not have moderate to severe aphasia or facial palsy were administered the PHQ-2.
The average LOS for the MSU and ARU were 5.2 and 10.2 days respectively. Only 1 patient met
the criteria for PHQ-9 screening. The patient scored less than 10 in the PHQ-9 and was
considered not depressed at the time of screening.
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At month 2 of project go-live, a total of 10 stroke patients (5 in the MSU and 5 in the
ARU) who did not have moderate to severe aphasia or facial palsy were administered the PHQ-2.
The average LOS for the MSU and ARU were 5.0 and 10.6 days respectively. Two patients met
the criteria for PHQ-9 screening and scored 10 or more, and were considered as depressed at the
time of screening. Both patients were started on a low-dose SSRI.
At month 3 of project go-live, a total of 7 stroke patients (4 in the MSU and 3 in the
ARU) who did not have moderate to severe aphasia or facial palsy were administered the PHQ-2.
The average LOS for the MSU and ARUU were 6.2 and 10.2 days respectively. Only 1 patient
met the criteria for PHQ-9 screening and scored 10 or more. The patient was considered as
depressed at the time of screening. The patient was started on a low-dose SSRI.
A total number of 82 nurses completed the post-live survey. A high number of nurses
expressed moderate to high comfort levels in administering BH screening tools on stroke
patients, with a rate of 36.58% and 47.56% respectively. A few nurses reported no to low
comfort levels, with a rate of 3.65% and 2.43% respectively, while 9.75% reported feeling
neither comfortable nor uncomfortable in administering BH screening tools to stroke patients. A
high number of nurses also reported moderate to high comfort levels in answering questions
from patients and family members as to why BH screening tools are being administered, with a
rate of 34.14% and 47.56% respectively. A few nurses reported no to low comfort levels, both
with a rate of 2.43%, while 13.41% reported feeling neither comfortable nor uncomfortable in
answering questions from patients and family members as to why BH screening tools are being
administered. Nurses who responded to the post-live survey reported moderate to high
confidence in the value of BH screening tools on patients as it relates to stroke patient outcomes,
with a rate of 47.56% and 52.43% respectively. A high number of nurses reported that they
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either somewhat agree or agree on recommending the use of BH screening tools on stroke
patients, with a rate of 46.34% and 53.65% respectively, while 3.65% reported being unsure
whether to recommend or not. Additionally, 30.48% of nurses admitted that they have reported
to a provider that a stroke patient may require a BH consult or intervention at one point. Majority
of the nurses reported observing behavioral changes from stroke patients 2 to 3 days, posthospital admission.

DEPRESSION SCREENING AND EARLY INTERVENTION

42

Section IV: Results
Program Evaluation and Outcomes
Several numerical changes were noted after comparing the results of the pre-live with the
post-live staff surveys. For the reported comfort levels in administering BH screening tools on
stroke patients: (a) there was a decrease of 2.92% in nurses feeling uncomfortable, (b) there was
a decrease of 9.08% in nurses feeling somewhat uncomfortable, (c) there was a decrease of
4.72% in nurses neither feeling comfortable nor uncomfortable, (d) there was a decrease of
2.89% in nurses feeling somewhat comfortable, while (e) there was an increase 18.52% in nurses
feeling comfortable. For the reported comfort levels in answering questions from patients and
family members as to why the BH screening tool was being administered: (a) there was a
decrease of 2.85% in nurses feeling uncomfortable, (b) there was a decrease 6.78% in nurses
feeling somewhat uncomfortable, (c) there was a decrease of 2.37% in nurses feeling neither
comfortable nor uncomfortable, (d) there is a decrease of 2.7% in nurses feeling somewhat
comfortable, while (e) there was an increase of 14.67% in nurses feeling comfortable. For the
reported confidence in the value of administering BH screening tools on stroke patients: (a) there
was an increase of 4.14% in nurses reporting some confidence, and (b) there was a decrease of
4.14% in nurses reporting confidence. For recommending the use of BH screening tools on
stroke patients: (a) there was a decrease of 2.92% in nurses who would neither recommend nor
not recommended, (b) there was an increase of 4.97% in nurses who would recommend, while
(c) there was an increase of 21.02% in nurses who would recommend. Additionally, BH changes
are still observed by nurses 2 to 3 days post-hospital admission. There was no significant change
in reporting rate by nurses for PSD interventions to providers.
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After reviewing the total number of admitted stroke patients for the 3 month period of
project go-live, a total of 27 patients were identified as not having moderate to severe aphasia of
facial palsy and were administered the PHQ-2 screening tool. Five out of these 27 patients scored
3 or more on the PHQ-2 and were administered the PHQ-9 screening tool. Only 3 of these 5
patients scored 10 or more on the PHQ-9 and considered depressed. The number of positive PSD
screens for post-stroke patients is significantly below the expected rate of 33%, with the actual
rate being at 11%. All patients with positive PSD screens were afforded early intervention and
were started on a low-dose SSRI. Additionally, all admitted stroke patients, regardless of their
PHQ scores were provided informal CBT sessions by stroke nurses, through the hospitals stroke
education session held during the weekends, which involved topics like “how to cope with
changes in feelings after having a stroke”.
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Section V: Discussion
Summary
Despite the low volume of stroke patients admitted in the hospital during the 3-month
period, the project was moderately successful on multiple levels. The project produced the
intended outcomes of cost-effective staff training and education on the timely administration of
PSD screening measures and intended pharmacological interventions. It was able to moderately
raise nurses’ comfort levels in the administration of BH screening questions and answering
questions related to its use. Additionally, nurses reported moderate increase in confidence the
overall clinical utility of PSD screening as part of the stroke care process. As a disruptive
innovation, it also exposed organizational stakeholders to the benefits of considering small tests
of change. The project was implemented during a period of high leadership turnover and when
the organization had just recently undergone its PSC re-certification, the project exemplified a
no-risk, low-key, and moderate-paced implementation. Overall success was dependent on the
widespread acceptance and support of all involved stroke care areas and enthusiastic
participation of resources and stroke care nurses. And although the project’s success on proving
improvement of stroke outcomes as it relates to timely screening and intervention of PSD was
considered low, due to several factors and limitations of the project, there appears to be a strong
link between good communication, good training, and staff compliance to small tests of change
aimed at improving patient care.
Relation to Other Evidence
Experimental Research
Kronenberg, Gertz, Heinz, and Endres (2014) conducted a translational research on
experiments conducted in modeling PSD in rodents via a variety of approaches. The researchers
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aimed to investigate short-term end points of acute stroke lesions and its relevance to the
development of PSD. The potential use of 5-hydroxytryptaminergic antidepressants as a
pharmacologic intervention for PSD was also explores. Four neurobiological changes in the
brain that contribute to behavioral changes and depressive-like symptoms post-stroke among
rodents (and other mammals) were identified: (a) the ability of the brain to capacity in building
new glia (neuroplasticity), (b) impaired neutropin signaling with decrease brain-derived
neurotropic factors (BDNF) concentrations seen post-mortem in suicide victims and patients
with mood disorders,(c) an increase in pro-inflammatory cytokines which is associated with
decrease reactivity from the social and physical environment, and (d) the rupturing of critical
neural pathways (neurodegeneration). The corrective actions of antidepressants and other mood
stabilizing agents after a stroke at the brain’s cellular and molecular levels were also validated.
The researchers concluded that outcomes in rodent stroke research may be of great value for
bridging the gap between clinical and other experimental perspectives in human stroke research.
Research outside the United States
Stroke and post-stroke complications are a growing public health concern worldwide. It
is estimated that frequency of reported PSD cases around the world range from 20% to 60%
(Ojagbemi, Akinyemi, & Baiyewu, 2014). Outside the US, several studies have been conducted
to determine the frequency and predictors of PSD. Ojagbemi et al. (2014), conducted a study on
130 stroke survivors in Nigeria undergoing rehabilitation over a 6-month period matched with a
control group of 130 healthy subjects, 60 males and 70 females. Most of the participants had
medical co-morbidities, such as systemic hypertension, and nearly one-quarter were either had a
history of alcohol abuse. Literacy was low, with 104 participants only having up to 6 years of
formal education while, while the remaining had none. Participants were referred by their
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primary care physicians (PCP). The aim of the study is to determine the frequency and predictors
of a Major Depressive Disorder (MDD) according to the DSM IV criteria using standardized
assessments in developing countries, such as Nigeria.
The Schedules for Clinical Assessment in Neuropsychiatry (SCAN) was used in the
diagnosis of a depressive disorder. At least 5 symptoms lasting 2 weeks or more meant that the
patient was depressed. The researchers reported that 41.5% of the participants met the criteria for
MDD post-stroke. The researchers believe that the morbidity in reported PSD may be associated
with the following factors: (a) mild stroke patients may not undergo rehabilitation or follow
through with referrals, (b) inefficient treatment of stroke at its acute phase, (c) a large proportion
of patients may present with traditional or sociocultural beliefs about stroke (e.g. faith healers,
etc.), and (d) limited access to health care services. The researchers concluded that although the
association between socio-economic risk factors for PSD were not directly studied, the social
economic changes in developing countries may also contribute the bi-directional relationship
between disability and depression.
Non-Pharmacologic Treatments
The most prevalent intervention for post-stroke neuropsychiatric disorders are
pharmacological agents. Currently, there is no universally accepted non-pharmacological
treatment for PSD. The reactive aspect of stroke such as functional impairment and PSD has
been subject to much debate. However, it has been suggested that PSD arise from the patient’s
inadequate adjustment to the consequences of the stroke and significance to loss of functioning.
Behavior change potential for stroke patients is limited. The traditional CBT approach of
modifying irrational, self-defeating and other negative thoughts do not typically work for stroke
patients who have sensory, motor, and cognitive impairments. Kootker et al. (2015) proposed a

DEPRESSION SCREENING AND EARLY INTERVENTION

47

new psychological treatment protocol in the form of a stroke-specific cognitive behavioral
therapy (CBT). The intervention supports the inclusion of occupational and movement during
therapy sessions by modifying existing CBT intervention for chronic disease to be strokespecific.
The researchers conducted a pilot study on 5 patients and integrated 5 psychological
approaches to CBT: (a) enhancement of motivation for behavioral change through motivational
interviewing, (b) promotion of grief resolution, (c) explanation of the relationship between
thought, feelings, and actions (Cognitive deficits adaptation), (d) selective optimization with
compensation through occupational and movement therapy, and (e) executive skills training
through relaxation techniques. The aim of the intervention is to improve self-efficacy by
providing cognitive tools to effect positive behavioral change. Participants attended 15-16
individual CBT sessions, jointly facilitated by a psychologist and an occupational therapist.
Although the outcome of the study was not clearly defined, the researchers agree that the
proposed intervention is innovative through its inclusion of occupational and movement therapy
and concurrently addressing post-stroke anxiety complaints.
Limitations
Because of the scope and constraints of the project, the project manager acknowledges
several short-comings. The project limitations identified are the following:


The number of admitted stroke patient who met criteria for PSD screening was low. A
large population is required to sufficiently measure the clinical utility of revising current
stroke care processes to include PSD screening.
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The heterogeneous entry of stroke patients in to the hospital, either through the ED or via
inter-facility transfer and directly in to the ARU, also meant that stroke patients screened
for PSD are at varying stages post-stroke.



The chosen screening tools, the PHQ-2 and PHQ-9, are language-based measures
necessitating the exclusion of patients with moderate to severe aphasia and facial palsy patients that may also screen positive for depression had a non-language based tool was
administered.



Only two treatment modalities / interventions were administered for positive screens: (a)
SSRIs and (b) pseudo-CBT.



SSRIs, the first-line agent for PSD and other mood disorders typically take 4 or more
weeks to take effect. The scope of the project did not involve measuring the efficacy of
pharmacologic interventions for PSD after hospitalization.



Cognitive decline and other post-stroke deficits are continuously monitored at each shift
through the use of the NIHSS. However, PSD screening was done only at one point (72
hours after admission) and not at multiple points during the patient’s hospitalization.

Conflict of Interest
The project manager acknowledges that there are no financial or personal relationships
between him and others involved that might bias this project.
Interpretation
Although this project was ideally suited for implementation on a much larger scale that
would encompass all 4 identified stroke care areas (ED, MSU, ICU, and ARU), it was successful
implemented in only the two high volume units, the MSU and ARU. Despite the lack of a
clinical alert (in the EHR) for nurses to screen, and varying levels of reported comfort in
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administering BH screening tools and answering questions from patients and family members as
to why the BH tool is being administered, compliance with PSD screening was high. The project
manager assumes that high compliance was affected by the following: (a) stroke is a hospital
core measure and is already a closely monitored condition, (b) effective teaching in the use of the
screening tool, and (c) easy administration / use of the chosen screening measure.
Conclusions
The biological and psychosocial theories of PSD can be an excellent guide in determining
higher risk populations and providing a timeline on when to observe for depressive symptoms.
The neurochemical changes in the brain provide an excellent framework for pharmacologic
management of depressive symptoms and the efficacy of SSRIs in treating PSD are well
documented. Although, tests to determine lesion location are part of conventional stroke care, the
inclusion of additional invasive procedures and tests to assess for neurochemical and other
microenvironment changes in the brain can prove too costly and may add to the stroke patient’s
distress. Rather than inflating the cost of hospitalization and exposing the patient to several
invasive procedures, the administration of a simple clinical tool for PSD screening is more costeffective and ethical.
Nurses play an important role in all the phases of stroke care and stages of stroke
recovery. They are at key position in detecting depressive symptoms and advocating for BH
interventions for stroke patients. Although PSD screening is only recommended for PSCs, the
inclusion of validated depression screening measure with conventional stroke care processes
should be integrated in all levels of stroke care to enable early detection, treatment, and
improving overall stroke outcomes.
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Section VI: Other Information
Funding
Funding for this project and any future publication was directly provided by the project
manager. Incidental support activities such as staff education and training by resource nurses are
not included in the project budget and were provided by the project site volunteers and
organizational leaders.
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Appendix C
Work Breakdown Structure
Post-Stroke Depression Screening
and Early Intervention Project

Review
PSD
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1.1

Map
current
stroke
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1.2
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1.3

Create
tool kit

1.4
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units

Train
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1.5
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Review
PSD
Etiology
Literature

Perform
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Review
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Train
resource
nurses

Pilot in
ED and
ICU

1.1.1

1.2.1

1.3.1
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Screening
Literature

Map
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screening
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1.1.2

1.2.2
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MSU
and
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printing

Go-live
on stroke
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1.7

1.8
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resource
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Data
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Submit DNP
with revisions

1.7.1

1.8.1

2.2

Evaluate
project

Present
project to
committee

1.8.2

1.5.2

Present
findings

1.8.3

Conduct
survey

1.9

Integrate
findings into
DNP paper

2.1

2.3
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Appendix D
Project Resource Requirements Table
Work Package

WBS ID

Activity

Predecessor

Duration in
Weeks

Review of Evidence

1.1

Review PSD Guidelines

N/A

4

Review of Evidence

1.1.1

Review PSD Etiology
Literature

1.1

6

Review of Evidence

1.1.2

Review PSD Screening
Literature

1.1

6

Review of Evidence

1.1.2.1

Identify Validated
Depression Screening Tool

1.1.2

2

Workflow Mapping

1.2

Map current stroke care
workflow

1.1

2

Gap Analysis

1.2.1

Perform Gap Analysis

1.2

1

Workflow Mapping

1.2.2

Map proposed PSD
screening workflow

1.2.1

2

Pre Go-live Survey

1.3

Conduct pre-live survey

1.2.1

2

Pre Go-live Survey

1.3.1

Review survey results

1.3

1

Training

1.4

Create tool kit

1.3.1

1

Training

1.4.1

Train resource nurses

1.4

1

Testing

1.5

Identify high volume units

1.4

1

Testing

1.5.1

Pilot in ED and ICU

1.5

4

Testing

1.5.2

Pilot in MSU and ARU

1.5

4

Training

1.6

Train stroke care nurses

1.4

4

Screening Tool

1.7

Screening tool printing

1.1.2.1

1

Screening Tool

1.7.1

Assemble resource binder

1.7

1

Project Go-live

1.8

Go-live on stroke care units

1.6

12

Project Go-live

1.8.1

Data Mining

1.8

8

Project Go-live

1.8.2

Project Evaluation

1.8.1

8

Project Go-live

1.8.3

Present findings to
organizational leadership

1.8.2

1

Post Go-live Survey

1.9

Conduct post-live survey

1.8

2

Write-up

2.1

Integrate findings into DNP
paper

1.9

6

Write-up

2.2

Submit DNP with revisions

2.1

2

Write-up

2.3

Present project to committee

2.2

1
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Appendix E

Literature review.
Identification of
Project Site.
Identification of
project sponsor.
IRB Clearance.
Meet with MSU
Nurse Manager.
Meet with ARU
Nurse Manager.
Meet with Stroke
Coordinator.
Identification of
resource nurses.
Pre-live survey.
Testing (ED & ICU)
Identification of new
project sponsor.
Testing (MSU &
ARU)
Staff training.
Submission of
project prospectus.
Identification of new
project sponsor.
Project go-Live.
Data mining.
Post-live survey.
Present findings to
hospital leadership.
Submission of DNP
paper.
Submission of DNP
paper with revisions.
Present project to
committee.

Dec. 2015

Nov. 2015

Oct. 2015

Sept. 2015

Aug. 2015

July 2015

June 2015

May 2015

Apr. 2015

Mar. 2015

Feb. 2015

Jan. 2015

Dec. 2014

Nov. 204

Oct. 2014

Sept. 2014

Aug. 2014

July 2014

June 2014

May 2014

Activity

Apr. 2014

Gantt Chart
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Appendix F
Financial Report
Expenses

Budget

Actual

Var.

$1080.00

$978.50

9.39%

$500.00

$536.75

-7.35%

$1580.00

$1515.25

4.09%

Direct Expenses
$300.00

Printing / Copying Services *
Transportation Expense
Gas

$150.00

Parking (Student rate at $8 per day)

$320.00

$470.00

Volunteer Meals

$100.00

Catering Costs (Day of project go-live)

$300.00

Indirect Expense
Office Supplies Expense **

$50.00

Other (Unforeseen) Expenses

$300.00

Token of Appreciation

$150.00

(for project sponsor and resource nurses)

Total Direct & Indirect Expenses
Estimated Opportunity Costs ***

$33469.60

Project hours of project manager
(535 hours at $62.56 per hour)

Project hours of resource nurses ($56 per hour)
Resource nurse A (80 hours)

$4480.00

Resource nurse B (80 hours)

$4480.00

Resource nurse C (40 hours)

$2240.00

Resource nurse D (40 hours)

$2240.00

Total Opportunity Costs

* Include binding costs for resource manuals.
** Include papers, folders, and other office supplies.
*** For reference only. Not part of the budget.

$13440.00
$46909.60
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Workflow Map

Stroke patient admitted to the unit.

RN completes the admission database and
NIHSS.

Patient is logged into the stroke census.

Patient is 72 hours post-admission.

Patient rates 0 to 2 for
presence of facial palsy?

YES

NO
Patient rates 0 to 1 for
presence of aphasia?

RN continues with routine stroke care.

YES

NO
RN administers the PHQ-2.

Patient rates 3 or more on
the PHQ-2?

NO

YES

RN documents the pHQ-2 in the EHR,
files the completed form in the paper,
and continues with routine stroke care.

RN administers the PHQ-9.

Patient rates 10 or more
on the PHQ-9?

NO

YES
RN files the completed questionnaires,
documents the PHQ-9 score, and notifies
attending provider.

Attending provider reviews the patient’s
PHQ-9 score and decides on appropriate
BH intervention (e.g. BH consult, start
on antidepressant, etc.).
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Patient Health Questionnaire-2
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Appendix I
Patient Health Questionnaire-9
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Appendix J
National Institutes for Health Stroke Scale (Items 1a-3)
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Appendix K
National Institutes for Health Stroke Scale (Items 4-9)

66

DEPRESSION SCREENING AND EARLY INTERVENTION
Appendix L
National Institutes for Health Stroke Scale (Items 10-11)
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Appendix M
SWOT Analysis
Strengths

Weaknesses

 TJC-certified PSC.

 Small urban hospital with several
neighboring GACHs.

 Stroke certified nurses.

 Poor NIHSS compliance by staff.

 Clinical nurse ladder program.

 Lack of a stroke coordinator.

 One of the few hospitals with an
inpatient BHU and onsite BH
providers.

 Location (Tenderloin area).
 Lengthy process for approval of EHR
build requests.

 One of the few hospitals with an
inpatient ARU.

 Lack of BH screening measures in the
current EHR system.

Opportunities

Threats

 Utilization of BH consults on
depressed stroke patients.
 Changes in organizational leadership.

 Staff nurse III/IVs involvement in QI
projects.

 Other designated PSCs and CSCs in the
area.

 Quality improvement on current
stroke care processes through the
inclusion of PSD screening and
intervention(s).

 Change fatigue and change resistance at
the staff level.
 Concurrent Q! projects competing for
resources.

 Staff education on PSD etiology,
onset, signs and symptoms, treatment,
and recovery.
 Standardization of depression
screening documentation.

`
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Appendix N
Pre-live Project Survey Questionnaire
Survey Questions
Rating Scale

Disagree

Somewhat
Disagree

Neither
Agree nor
Disagree

Somewhat
Agree

Agree

1

2

3

4

5

Total

%

I am comfortable in administering
behavioral health screening tools
on stroke patients.

I am comfortable in answering
questions from patients and
family members as to why
behavioral health screening tools
are being administered.

I believe in the value of
administering behavioral health
screening tools on patients as it
relates to stroke patient outcomes.

I would recommend the use of
behavioral health screening tools
on stroke patients.

Total

□ Did not observe any
At what day after admission do
you typically observe behavioral
changes (e.g. irritable, crying
spells, socially withdrawn, etc.)
from stroke patients? Please select
one.
Have you ever reported to a
provider that a post-stroke patient
may require a behavioral health
consult or intervention?

Comments:

behavioral changes.

□ Same day after admission.
□ 1 day after admission.
□ 2 days after admission.
□ Yes
□ No

□ 3 days after admission.
□ 4 days after admission.
□ 5 days or more after
admission. Please specify: ___
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Appendix O
Post-live Project Survey Questionnaire
Survey Questions
Rating Scale

Disagree

Somewhat
Disagree

Neither
Agree nor
Disagree

Somewhat
Agree

Agree

1

2

3

4

5

Total

%

I am comfortable in administering
behavioral health screening tools
on stroke patients.

I am comfortable in answering
questions from patients and
family members as to why
behavioral health screening tools
are being administered.

I believe in the value of
administering behavioral health
screening tools on patients as it
relates to stroke patient outcomes.

I would recommend the use of
behavioral health screening tools
on stroke patients.

Total
Have you ever reported to a
provider that a post-stroke patient
may require a behavioral health
consult or intervention?
At what day after an intervention
(e.g. antidepressants, brief
psychotherapy, etc.) had been
initiated did you observe
improvement in the patient’s
behavior? Please select one.

Comments:

□ Yes
□ No
□ Did not observe any
improvement in behavior.

□ Same day.
□ After 1 day.
□ After 2 days

□ After 3 days.
□ After 4 days.
□ 5 days or more after
intervention has been started.
Please specify: ___
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Appendix O
Staff Survey Results
Pre-Live Survey Results
Duration: 4 weeks Number of Respondents: 76
1

%

2

%

3

%

4

%

5

%

I am comfortable in administering behavioral
health screening tools on stroke patients.

5

6.57

8

10.52

11

14.47

30

39.47

22

28.94

I am comfortable in answering questions from
patients and family members as to why
behavioral health screening tools are being
administered.

4

5.26

7

9.21

12

15.78

28

36.84

25

32.89

I believe in the value of administering
behavioral health screening tools on patients as
it relates to stroke patient outcomes.

0

0

0

0

0

0

33

43.42

43

56.57

I would recommend the use of behavioral
health screening tools on stroke patients.

0

0

0

0

5

6.57

39

51.31

37

48.68

Have you ever reported to a provider that a
post-stroke patient may require a behavioral
health consult or intervention?

Yes

23

%

30.3

No

53

%

69.7

At what day after admission do you typically
observe behavioral changes (e.g. irritable,
crying spells, socially withdrawn, etc.) from
stroke patients? Please select one.
Never

%

Same
day

%

After
1 day

%

After 2
days

%

After 3
days

%

After 4
days

%

After
5 days
or >

%

0

0

4

5.26

5

6.57

17

22.36

36

47.36

10

13.15

4

5.26

Post-Live Survey Results
Duration: 4 weeks Number of Respondents: 82
1

%

2

%

3

%

4

%

5

%

I am comfortable in administering behavioral
health screening tools on stroke patients.

3

3.65

2

2.43

8

9.75

30

36.58

39

47.56

I am comfortable in answering questions
from patients and family members as to why
behavioral health screening tools are being
administered.

2

2.43

2

2.43

11

13.41

28

34.14

39

47.56

I believe in the value of administering
behavioral health screening tools on patients
as it relates to stroke patient outcomes.

0

0

0

0

0

0

39

47.56

43

52.43

I would recommend the use of behavioral
health screening tools on stroke patients.

0

0

0

0

3

3.65

38

46.34

44

53.65

Have you ever reported to a provider that a
post-stroke patient may require a behavioral
health consult or intervention?

Yes

25

%

30.48

No

57

%

69.51

At what day after an intervention (e.g.
antidepressants, brief psychotherapy, etc.)
had been initiated did you observe
improvement in the patient’s behavior?
Please select one.
Never

%

Same
day

%

After 1
day

%

After 2
days

%

After 3
days

%

After 4
days

%

After 5
days or
>

%

0

0

8

9.75

6

7.31

19

23.17

34

41.46

12

14.63

3

3.65
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Appendix P
Screening and Intervention Results
Testing (1 Month)
Stroke
Care Unit

# of
Stroke
Patients

Pre-PSD
Screening
NIHSS

# of
PHQ-2
Score > 3

# of
PHQ-9
Score > 10

# of
(+) PSD
Intervention

# of
FALL

Average
LOS

Pre-DC
NIHSS

# of
Readmits

ED

3

N/A

0

0

0

0

No data

N/A

0

ICU

3

N/A

0

0

0

0

6.2

N/A

0

MSU

5

N/A

0

0

0

0

4.9

N/A

0

ARU

4

16

1

0

0

0

10.1

12

0

Average
LOS

Pre-DC
NIHSS

# of
Readmits

Project Live Month 1
Stroke
Care Unit

# of
Stroke
Patients

Pre-PSD
Screening
NIHSS

# of
PHQ-2
Score > 3

# of
PHQ-9
Score > 10

# of
(+) PSD
Intervention

# of
FALL

MSU

4

N/A

0

0

0

0

5.2

N/A

0

ARU

6

14

1

0

0

0

10.2

12

0

Average
LOS

Pre-DC
NIHSS

# of
Readmits

Project Live Month 2
Stroke
Care Unit

# of
Stroke
Patients

Pre-PSD
Screening
NIHSS

# of
PHQ-2
Score > 3

# of
PHQ-9
Score > 10

# of
(+) PSD
Intervention

# of
FALL

MSU

5

18

1

1

1

0

5.0

13

0

ARU

5

15

1

1

1

0

10.6

12

0

Average
LOS

Pre-DC
NIHSS

# of
Readmits

Project Live Month 3
Stroke
Care Unit

# of
Stroke
Patients

Pre-PSD
Screening
NIHSS

# of
PHQ-2
Score > 3

# of
PHQ-9
Score > 10

# of
(+) PSD
Intervention

# of
FALL

MSU

4

N/A

2

0

0

0

6.2

N/A

0

ARU

3

15

1

1

1

0

10.2

10

0

MSU Results Summary
Stages

# of
Stroke
Patients

Pre-PSD
Screening
NIHSS

# of
PHQ-2
Score > 3

# of
PHQ-9
Score > 10

# of
(+) PSD
Intervention

# of
FALL

Average
LOS

Pre-DC
NIHSS

# of
Readmits

Test

5

N/A

0

0

0

0

4.9

N/A

0

Month 1

4

N/A

0

0

0

0

5.2

N/A

0

Month 2

5

18

1

1

1

0

5.0

13

0

Month 2

4

N/A

2

0

0

0

6.2

N/A

0

ARU Results Summary
Stages

# of
Stroke
Patients

Pre-PSD
Screening
NIHSS

# of
PHQ-2
Score > 3

# of
PHQ-9
Score > 10

# of
(+) PSD
Intervention

# of
FALL

Average
LOS

Pre-DC
NIHSS

# of
Readmits

Test

4

16

1

0

0

0

10.1

12

0

Month 1

6

14

1

0

0

0

10.2

12

0

Month 2

5

15

1

1

1

0

10.6

12

0

Month 2

3

15

1

1

1

0

10.2

10

0
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Training Handouts
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Appendix R
Betty Neuman’s System Model
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Appendix S
Evidence Table
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Appendix T
Cost Savings Table
PSD PATIENTS IN THE MSU WHO RECEIVED PHARMACOLOGIC INTERVENTION
MEDI-CAL DRG

PROJECT SITE

LOS

DRG BASE

RATE/DAY

# (+) CASES

MSU LOS

∆ LOS

SAVINGS

MONTH 1

7.65

$17415

$2276.47

0

N/A

N/A

N/A

MONTH 2

7.65

$17415

$2276.47

1

5.0

2.65

$6032.64

MONTH 3

7.65

$17415

$2276.47

0

N/A

N/A

N/A

PSD PATIENTS IN THE ARU WHO RECEIVED PHARMACOLOGIC INTERVENTION
MEDI-CAL DRG

PROJECT SITE

LOS

DRG BASE

RATE/DAY

# (+) CASES

MSU LOS

∆ LOS

SAVINGS

MONTH 1

14.75

$10410

$705.76

0

N/A

N/A

N/a

MONTH 2

14.75

$10410

$705.76

1

10.6

4.15

$2928.90

MONTH 3

14.75

$10410

$705.76

1

10.2

4.55

$3211.21

PSD PATIENTS IN THE MSU WHO RECEIVED PHARMACOLOGIC INTERVENTION
LOS

DRG BASE

RATE/DAY

# (+) CASES

MSU LOS

(MSU LOS X
1.71) – MSU
LOS

MONTH 1

7.65

$17415

$2276.47

0

N/A

N/A

N/A

MONTH 2

7.65

$17415

$2276.47

1

5.0

3.55

$8079.8

MONTH 3

7.65

$17415

$2276.47

0

N/A

N/A

N/A

MEDI-CAL DRG

PROJECT SITE

SAVINGS

PSD PATIENTS IN THE ARU WHO RECEIVED PHARMACOLOGIC INTERVENTION
LOS

DRG BASE

RATE/DAY

# (+) CASES

MSU LOS

(ARU LOS X
1.71) – ARU
LOS

MONTH 1

14.75

$10410

$705.76

0

N/A

N/A

N/A

MONTH 2

14.75

$10410

$705.76

1

10.6

7.526

$5311.54

MONTH 3

14.75

$10410

$705.76

1

10.2

7.242

$5111.11

MEDI-CAL DRG

PROJECT SITE

SAVINGS

COST SAVINGS

$30675.2

LESS: ACTUAL DIRECT AND INDIRECT EXPENSES

$1515.25

NET SAVINGS OVER A 3-MONTH PERIOD

$29159.95

